New doors open for Cytokine drug developers to treat diseases both in and beyond oncology with novel masking and tissue targeting mechanisms and the abundance of preclinical and clinical efficacy data as more companies get additional funding to boost their pipelines.
Now's the time to join forces with key decision-makers including Sanofi, Moderna, Xencor, CytomX and more at the 4th Cytokine-Based Drug Development Summit, the only industry focused event exclusively addressing your discovery, translational and reverse translational challenges.
This meeting will equip you with the latest scientific insights to develop a cytokine drug with reduced toxicities, enabling you to dose at the right level and witness greater clinical benefit to patients.
Read on cytokine-based-drugdevelopment.com
Continue reading at cytokine-based-drugdevelopment.com
June 28 to June 29, 2023
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2023 Netspective Media LLC. All Rights Reserved.
Built on Mar 30, 2023 at 7:39am